obesity

biolink:Disease biolink:DiseaseOrPhenotypicFeature biolink:BiologicalEntity biolink:ThingWithTaxon biolink:NamedThing


Angina pectoris

biolink:PhenotypicFeature biolink:DiseaseOrPhenotypicFeature biolink:BiologicalEntity biolink:ThingWithTaxon biolink:NamedThing


immunodeficiency 11b with atopic dermatitis


attention deficit hyperactivity disorder, inattentive type


autosomal dominant intermediate Charcot-Marie-Tooth disease with neuropathic pain


restless legs syndrome, susceptibility to, 1


metastatic malignant neoplasm in the brain


Chemotherapy-induced nausea and vomiting


coronary artery disease, autosomal dominant, 1


autosomal dominant polycystic liver disease


respiratory syncytial virus infectious disease


congenital herpes simplex virus infection


myelodysplastic syndrome with ring sideroblasts


adult acute respiratory distress syndrome


primary cutaneous peripheral T-cell lymphoma not otherwise specified


susceptibility to visceral leishmaniasis, 2


metabolic dysfunction-associated steatotic liver disease


chronic myelogenous leukemia, BCR-ABL1 positive


autosomal recessive inherited pseudoxanthoma elasticum


beta-methylene thiazole-4-carboxamide adenine dinucleotide


chronic lymphocytic leukemia/small lymphocytic lymphoma


Bictegravir, emtricitabine and tenofovir alafenamide


isolated growth hormone deficiency type II


estrogen-receptor positive breast cancer


sulfite oxidase deficiency due to molybdenum cofactor deficiency


age at initiation of hormone replacement therapy


methicillin-resistant staphylococcus aureus infectious disease


autosomal dominant polycystic kidney disease


(2-Hydroxyimino-2-phenyl-ethyl)-carbamic acid tert-butyl ester


neonatal urinary tract infectious disease


3-[[(4-tert-butylphenyl)-oxomethyl]amino]-1H-1,2,4-triazole-5-carboxylic acid methyl ester


atypical chronic myeloid leukemia, BCR-ABL1 negative


Alogliptin Benzoate; Pioglitazone Hydrochloride


Metformin Hydrochloride; Sitagliptin Phosphate


neurobehavioral disorder with prenatal alcohol exposure


tenosynovial giant cell tumor, diffuse type


Status epilepticus without prominent motor symptoms


Talc (powder), containing no asbestos fibers


autoimmune disorder of the nervous system


1,8-Naphthyridine-3-carboxylic acid, 1,4-dihydro-7-(3-amino-4-methyl-1-pyrrolidinyl)-1-(1,1-dimethylethyl)-6-fluoro-4-oxo-, trans-(+-)-, monomethanesulfonate, hydrate


ventricular arrhythmias due to cardiac ryanodine receptor calcium release deficiency syndrome


vitamin K deficiency hemorrhagic disease


bisphenol A (3-chloro-2-hydroxypropyl) (2,3-dihydroxypropyl) ether


3-hydroxy-2-phenylpropanoic acid [(1R,5R)-8-methyl-8-propan-2-yl-8-azoniabicyclo[3.2.1]octan-3-yl] ester


Elevated circulating C-reactive protein concentration


CARBAMIC ACID, ALLYL-, m-(DIMETHYLAMINO)PHENYL ESTER, HYDROCHLORIDE


Carbamic acid, N-methyl-, 3-(alpha-dimethylaminoethyl)phenyl ester, hydrochloride


Ammonium, ((3-hydroxy-4-methoxy-alpha-methyl)benzyl)trimethyl-, iodide, methylcarbamate


Ammonium, (m-hydroxyphenyl)trimethyl-, methylsulfate, allylcarbamate


eosinophilic granulomatosis with polyangiitis


anti-neutrophil cytoplasmic antibody-associated vasculitis


Decreased circulating vitamin E concentration


Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 4


isolated thyroid-stimulating hormone deficiency


Budesonide and formoterol fumarate dihydrate


obesity, hyperphagia, and developmental delay


Benzoic acid, 2,6-dimethyl-, 2-(1-pyrrolidinyl)ethyl ester


precursor T-cell acute lymphoblastic leukemia


Combretastatin A-1 phosphate (tetrasodium)


genetic developmental and epileptic encephalopathy


Alogliptin Benzoate; METformin Hydrochloride


Phosphorodiamidic acid, N,N-bis(2-chloroethyl)-N'-(3-hydroxypropyl)-, (3-chloropropyl) ester


Reduced circulating growth hormone concentration


progressive familial intrahepatic cholestasis


coronary heart disease, susceptibility to, 5